Free Trial
→ Distracted Americans set to miss out on quadrillions (From Brownstone Research) (Ad)tc pixel Free MKL Stock Alerts

Markel Group (MKL) Short Interest Ratio & Short Volume

Markel Group logo
$1,840.65 +20.07 (+1.10%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Markel Group Short Interest Overview

As of April 30, 2026, Markel Group (MKL) had a short interest of 186,903 shares sold short, representing 1.51% of the public float. This marks a 1.25% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.2, meaning it would take 2.2 days of the average trading volume of 56,302 shares to cover all short positions.

Current Short Interest
186,903 shares
Previous Short Interest
184,591 shares
Change Vs. Previous Month
1.25%
Dollar Volume Sold Short
$331.72 million
Short Interest Ratio
2.2 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
12,510,000 shares
Short Percent of Float
1.51%
Today's Trading Volume
16,854 shares
Average Trading Volume
56,302 shares
Today's Volume Vs. Average
30%
Short Selling Markel Group?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Markel Group and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MKL Short Interest Over Time

MKL Days to Cover Over Time

MKL Percentage of Float Shorted Over Time

Markel Group Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026186,903 shares $331.72 million +1.3%1.5%2.22 $1,774.85
4/15/2026184,591 shares $366.48 million +1.3%1.5%3.56 $1,985.35
3/31/2026182,161 shares $348.26 million +8.1%1.5%3.34 $1,911.84
3/13/2026168,468 shares $327.15 million +7.3%1.4%3.35 $1,941.90
2/27/2026157,069 shares $324.95 million -9.1%1.3%3.42 $2,068.81
2/13/2026172,842 shares $356.21 million -9.3%1.4%3.39 $2,060.89
1/30/2026190,515 shares $388.87 million -2.5%1.5%3.62 $2,041.15
1/15/2026195,384 shares $406.89 million -5.7%1.6%4.8 $2,082.53
12/31/2025207,275 shares $445.78 million -5.9%1.7%6.26 $2,150.68
12/15/2025220,309 shares $474.71 million +2.1%1.8%4.72 $2,154.77
11/28/2025215,824 shares $449.01 million -15.4%1.7%4.88 $2,080.44
11/14/2025255,240 shares $525.90 million +18.7%2.1%5.42 $2,060.41
10/31/2025215,057 shares $424.73 million +1.2%1.7%5 $1,974.99
10/15/2025212,400 shares $407.11 million +8.2%1.7%5 $1,916.70
9/30/2025196,300 shares $375.50 million -2.9%1.6%4.6 $1,912.87
9/15/2025202,200 shares $389.44 million +11.8%1.6%4.7 $1,926.00
8/31/2025180,900 shares $354.47 million -6.4%1.5%4.2 $1,959.47
8/15/2025193,300 shares $372.77 million +9.5%1.6%4 $1,928.46
7/31/2025176,600 shares $355.01 million -11.0%1.4%3.5 $2,010.28
7/15/2025198,500 shares $392.69 million +11.1%1.6%4 $1,978.27
6/30/2025178,600 shares $356.49 million +11.1%1.4%3.2 $1,996.02
6/15/2025160,700 shares $309.87 million +8.0%1.3%2.9 $1,928.28
5/31/2025148,800 shares $288.40 million -0.8%1.2%2.6 $1,938.20
5/15/2025150,000 shares $285.16 million -12.7%1.2%2.7 $1,901.06
4/30/2025171,800 shares $311.73 million -17.2%1.4%2.7 $1,814.50
4/15/2025207,400 shares $369.70 million +19.8%1.7%3.3 $1,782.56
3/31/2025173,100 shares $323.18 million +8.6%1.4%2.6 $1,867.00
3/15/2025159,400 shares $294.94 million -8.0%1.3%2.5 $1,850.33
2/28/2025173,300 shares $335.26 million -3.1%1.4%2.6 $1,934.54
2/15/2025178,800 shares $334.18 million -3.3%1.4%2.8 $1,869.04
1/31/2025184,800 shares $338.09 million +19.4%1.5%3 $1,829.52
1/15/2025154,800 shares $270.48 million +4.0%1.2%2.7 $1,747.27
12/31/2024148,800 shares $256.86 million +3.6%1.2%3 $1,726.23
12/15/2024143,600 shares $249.26 million +0.6%1.1%3 $1,735.79
11/30/2024142,800 shares $254.60 million -0.3%1.1%3.1 $1,782.92
11/15/2024143,200 shares $244.53 million +20.2%1.1%3.4 $1,707.64
10/31/2024119,100 shares $183.65 million +4.8%0.9%3.2 $1,542.01
10/15/2024113,600 shares $177.47 million -4.6%0.9%3.2 $1,562.27
9/30/2024119,100 shares $186.82 million +7.6%0.9%3.3 $1,568.58
9/15/2024110,700 shares $172.42 million +5.0%0.9%2.9 $1,557.58
Microscopic Footage Shows Immune Cells Attacking Cancer (Ad)

Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel

Watch the footage and learn about the company's next catalyst
8/31/2024105,400 shares $168.71 million -2.5%0.8%2.7 $1,600.68
8/15/2024108,100 shares $167.08 million +6.5%0.9%2.8 $1,545.62
7/31/2024101,500 shares $166.34 million -18.3%0.8%2.5 $1,638.85
7/15/2024124,200 shares $198.40 million -4.7%1.0%3.1 $1,597.46
6/30/2024130,300 shares $205.31 million -8.0%1.0%3.2 $1,575.66
6/15/2024141,600 shares $218.64 million -8.5%1.1%3.6 $1,544.07
5/31/2024154,800 shares $254.31 million +0.3%1.2%4 $1,642.81
5/15/2024154,300 shares $253.01 million +5.7%1.2%3.6 $1,639.70
4/30/2024146,000 shares $213.24 million -13.7%1.2%3.1 $1,460.52
4/15/2024169,200 shares $241.46 million +17.1%1.3%3.3 $1,427.07
3/31/2024144,500 shares $219.85 million -11.8%1.1%2.9 $1,521.48
3/15/2024163,900 shares $249.63 million +4.3%1.3%3.3 $1,523.04
2/29/2024157,200 shares $234.76 million +0.1%1.2%2.8 $1,493.37
2/15/2024157,000 shares $230.68 million +15.0%1.2%2.5 $1,469.32
1/31/2024136,500 shares $204.66 million -4.0%1.1%2.1 $1,499.33
1/15/2024142,200 shares $203.32 million +4.4%1.1%2.2 $1,429.84
12/31/2023136,200 shares $193.39 million -12.2%1.1%2.1 $1,419.90
12/15/2023155,200 shares $216.28 million +43.0%1.2%2.4 $1,393.53
11/30/2023108,500 shares $155.91 million +53.0%0.8%1.7 $1,437.00
11/15/202370,900 shares $97.82 million +3.7%0.6%1.3 $1,379.68
10/31/202368,400 shares $100.58 million -5.1%0.5%1.5 $1,470.52
10/15/202372,100 shares $107.85 million +2.3%0.6%1.9 $1,495.87
9/30/202370,500 shares $103.81 million -0.6%0.5%2 $1,472.49
9/15/202370,900 shares $107.91 million -2.6%0.6%2.1 $1,521.94
8/31/202372,800 shares $107.60 million -9.3%0.6%2.2 $1,478.00
8/15/202380,300 shares $120.04 million +3.0%0.6%2.4 $1,494.94
7/31/202378,000 shares $113.10 million -27.7%0.6%2.4 $1,449.96
7/15/2023107,900 shares $148.85 million -1.6%0.8%3.3 $1,379.52
6/30/2023109,600 shares $151.48 million -4.7%0.8%3.3 $1,382.11
6/15/2023115,000 shares $153.50 million -5.4%0.9%3.3 $1,334.75
5/31/2023121,600 shares $159.75 million -3.3%0.9%3.3 $1,313.72
5/15/2023125,700 shares $172.31 million -2.9%1.0%3.4 $1,370.78
4/30/2023129,500 shares $177.22 million +2.6%1.0%3.4 $1,368.53
4/15/2023126,200 shares $166.54 million +19.9%1.0%3.2 $1,319.68
3/31/2023105,300 shares $134.51 million +6.7%0.8%2.7 $1,277.41
3/15/202398,700 shares $119.76 million +29.0%0.8%2.5 $1,213.33
2/28/202376,500 shares $101.73 million -11.1%0.6%2.2 $1,329.86
2/15/202386,000 shares $115.91 million -10.0%0.7%2.5 $1,347.82
1/31/202395,600 shares $134.70 million -7.2%0.7%2.8 $1,408.98
1/15/2023103,000 shares $148.32 million +14.1%0.8%3 $1,439.96
12/30/202290,300 shares $118.97 million -16.7%0.7%2.5 $1,317.49
12/15/2022108,400 shares $138.75 million +5.0%0.8%2.7 $1,280.00
11/30/2022103,200 shares $136.72 million -5.0%0.8%2.4 $1,324.84
11/15/2022108,600 shares $136.62 million +9.7%0.8%2.5 $1,258.03
10/31/202299,000 shares $119.40 million -22.7%0.8%2.2 $1,206.10
10/15/2022128,100 shares $145.21 million -7.5%1.0%2.6 $1,133.60
9/30/2022138,500 shares $150.16 million +18.2%1.0%2.5 $1,084.22
9/15/2022117,200 shares $139.63 million +17.1%0.9%2.2 $1,191.42
8/31/2022100,100 shares $119.53 million -5.7%0.8%2 $1,194.11
8/15/2022106,100 shares $130.55 million -1.0%0.8%2.1 $1,230.47
Microscopic Footage Shows Immune Cells Attacking Cancer (Ad)

Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel

Watch the footage and learn about the company's next catalyst
7/31/2022107,200 shares $139.05 million -24.3%0.8%2 $1,297.14
7/15/2022141,600 shares $180.20 million +10.7%1.1%2.7 $1,272.57
6/30/2022127,900 shares $165.41 million +10.9%1.0%2.6 $1,293.25
6/15/2022115,300 shares $149.80 million -0.9%0.9%2.2 $1,299.25
5/31/2022116,300 shares $159.26 million -15.8%0.9%1.9 $1,369.43
5/15/2022138,100 shares $183.04 million -0.4%1.0%2.1 $1,325.45
4/30/2022138,700 shares $187.70 million -9.1%1.0%2.2 $1,353.28
4/15/2022152,600 shares $225.09 million -12.9%1.2%2.4 $1,475.00
3/31/2022175,200 shares $258.46 million +36.5%1.3%2.8 $1,475.24
3/15/2022128,400 shares $176.27 million +73.8%1.0%2.3 $1,372.79
2/28/202273,900 shares $91.85 million +13.9%0.6%1.5 $1,242.91
2/15/202264,900 shares $81.83 million -11.5%0.5%1.4 $1,260.89
1/31/202273,300 shares $90.36 million -12.4%0.6%1.6 $1,232.74
1/15/202283,700 shares $106.85 million +4.0%0.6%2 $1,276.61
12/31/202180,500 shares $99.34 million +9.2%0.6%1.8 $1,234.00
12/15/202173,700 shares $90.41 million -3.7%0.6%1.6 $1,226.72
11/30/202176,500 shares $91.40 million -23.0%0.6%1.8 $1,194.82
11/15/202199,300 shares $126.89 million -8.8%0.7%2.5 $1,277.80
10/29/2021108,900 shares $143.00 million +9.9%0.8%2.9 $1,313.13
10/15/202199,100 shares $130.76 million +13.8%0.7%2.5 $1,319.45
9/30/202187,100 shares $104.10 million -25.0%0.7%2.4 $1,195.13
9/15/2021116,100 shares $141.64 million +36.4%0.9%3 $1,220.01
8/31/202185,100 shares $108.10 million -25.0%0.6%2.1 $1,270.25
8/13/2021113,400 shares $144.66 million +25.2%0.9%2.4 $1,275.69
7/30/202190,600 shares $109.28 million -34.9%0.7%1.7 $1,206.17
7/15/2021139,200 shares $167.44 million +14.1%1.0%2.6 $1,202.88
6/30/2021122,000 shares $144.78 million +11.7%0.9%2.3 $1,186.71
6/15/2021109,200 shares $132.65 million -41.8%0.8%2.2 $1,214.77
5/28/2021187,500 shares $229.78 million +36.4%1.4%3.8 $1,225.49
5/14/2021137,500 shares $166.70 million +35.9%1.0%3 $1,212.33

MKL Short Interest - Frequently Asked Questions

Short interest is the volume of Markel Group shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 186,903 shares of MKL short. 1.51% of Markel Group's shares are currently sold short. Learn More on Markel Group's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MKL shares currently have a short interest ratio of 2.2. Learn More on Markel Group's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Markel Group: Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.51% of Markel Group's floating shares are currently sold short.

Markel Group saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 186,903 shares, an increase of 1.3% from the previous total of 184,591 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.51% of Markel Group's shares are currently sold short. Here is how the short interest of companies compare to Markel Group: Arch Capital Group Ltd. (2.04%), Cincinnati Financial Corporation (1.87%), American Financial Group, Inc. (2.09%), Axis Capital Holdings Limited (1.67%), CNA Financial Corporation (0.86%), The Hartford Insurance Group, Inc. (2.20%), Loews Corporation (2.54%), The Hanover Insurance Group, Inc. (2.41%), The Travelers Companies, Inc. (2.33%), The Allstate Corporation (2.69%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling MKL is an investing strategy that aims to generate trading profit from Markel Group as its price is falling. MKL shares are trading down $10.98 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Markel Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MKL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MKL, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MKL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:MKL) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel